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Abstract
Background: Type II alveolar epithelial cells (AECII) are well known for their role in the innate immune system.
More recently, it was proposed that they could play a role in the antigen presentation to T lymphocytes but
contradictory results have been published both concerning their surface expressed molecules and the T
lymphocyte responses in mixed lymphocyte cultures. The use of either AECII cell line or fresh cells could explain
the observed discrepancies. Thus, this study aimed at defining the most relevant model of accessory antigen
presenting cells by carefully comparing the two models for their expression of surface molecules necessary for
efficient antigen presentation.
Methods: We have compared by flow cytometry the surface expression of the major markers involved in the
immunological synapse on the A549 cell line, the most popular model of type II alveolar epithelial cells, and freshly
isolated cells. HLA-DR, CD80, CD86, ICOS-L, CD54, CD58 surface expression were studied in resting conditions as
well as after IFN-g/TNF-a treatment, two inflammatory cytokines, known to modulate some of these markers.
Results: The major difference found between the two cells types was the very low surface expression of HLA-DR
on the A549 cell line compared to its constitutive expression on freshly isolated AECII. The surface expression of
co-stimulatory molecules from the B7 family was very low for the CD86 (B7-2) and ICOS-L (B7-H2) and absent for
CD80 (B7-1) on both freshly isolated cells and A549 cell line. Neither IFN-g nor TNF-a could increase the expression
of these classical co-stimulatory molecules. However CD54 (ICAM-1) and CD58 (LFA-3) adhesion molecules, known
to be implicated in B7 independent co-stimulatory signals, were well expressed on the two cell types.
Conclusions: Constitutive expression of MHC class I and II molecules as well as alternative co-stimulatory
molecules by freshly isolated AECII render these cells a good model to study antigen presentation.
Background
Type II alveolar epithelial cells (AECII) are since long
recognized as important players of the innate immune
system, secreting antimicrobial proteins like surfactant
p r o t e i nA ,Ca n dD ,b u ta l s op r o d u c i n gav a r i e t yo f
cytokines and chemokines [1-3]. Due to their location,
they are exposed to microbes reaching the alveolus and
can be infected by several infectious agents, such as
influenza virus, severe acute respiratory syndrome-coro-
navirus, Legionella pneumophila, Bacillus anthracis or
Mycobacterium tuberculosis which is well known to
multiply and to survive within AECII [4-10]. Indeed
alveolar epithelial cells are being by far more numerous
than the macrophages, the phagocytic cell prototype
[11]. However besides the AECII, the alveolar surface is
also covered by type I AEC but these cells mostly play a
role for gaz exchange [12]. In contrast, cuboidal AECII
were suggested to play a possible role of non-profes-
sional antigen-presenting cells as they were reported to
express both class I and class II major histocompatibility
complex molecules (MHC) [13]. Interestingly, AECII are
in contact with a huge amount of lymphocytes, the cells
involved in the development of specific immune
responses. Indeed, the number of lymphocytes in the
lung interstitium has been reported to be 10
10,w h i c hi s
similar to the number of circulating lymphocytes [14].
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zation of the AECII phenotype and more precisely on
the detection of surface molecules involved in antigenic
presentation. As T-cell receptor engagement and co-sti-
mulatory signals are usually required for the full activa-
tion of T cells, different authors have analyzed the
expression of co-stimulatory molecules by AECII. How-
ever, several contradictory results were published, each
paper focusing on a limited amount of phenotypic mar-
kers. Major differences between the results might be
explained by technical differences between the studies
[13,15-19]. In addition, most studies were performed on
a human tumor cell line, the A549, defined as a model
of human AECII [20], as freshly isolated AECII from
human pulmonary pieces are rather difficult to obtain.
The aim of the study was to compare both models
and to define the most suitable one to study antigen
presentation. In this paper, we report a detailed pheno-
typic analysis of human AECII comparing the human
tumor cell line A549 to freshly isolated human AECII.
We have characterized the expression of MHC-class II
molecules and the expression of different co-stimulatory
molecules known to be involved in the immunological
synapse, CD80, CD86, ICOS-L, CD40, CD54, CD58.
The expression of these molecules was analyzed first on
resting cells and then on cytokine-activated cells. To
mimic inflammation, we chose to analyze the effect on
the AECII phenotype of two major inflammatory cyto-
kines, IFN-g and TNF-a, known to modulate some of
these surface molecules [17,21-26].
Methods
A549 cell line culture
A549, a human alveolar type II epithelial cell line from an
adenocarcinoma (LGC Promochem, UK/ATCC
®;N u m -
ber: CCL-185™) was maintained in Dulbecco’sm o d i f i e d
Eagle’s medium (DMEM, LONZA, Verviers, Belgium)
supplemented with 10% heat-inactivated foetal calf
serum (FCS, PAA Laboratories GmbH, Pashing, Austria)
at 37°C in a 5% CO2 atmosphere. For the experiments,
the cell line was used from the 5
th to the 13
th passage.
Human pulmonary type II alveolar epithelial cells
After ethical committee agreement (Comité d’Ethique-
Hôpital Erasme, reference number P2007/175), AECII
were isolated from macroscopically tumor free regions
of lung tissues obtained following lobectomy or pneu-
mectomy for lung cancer. The AECII isolation was
adapted from a previously described technique [27].
After differential adherence of contaminating mononuc-
lear cells, non-adherent AECII were plated at 5 × 10
5
cells/well in 48 wells flat-bottomed plates precoated
with type I collagen (1%) to obtain pure AECII [28].
Cells reached confluence after 24 or 48 hours.
The purity averaged 85.78% (81.78% - 90.03%) (median,
inter-quartile ranges) for the nine independent AECII
isolations as assessed by flow cytometry (see below).
Flow cytometry
This technique was used to assess the purity of the cell
suspensions and to characterize their phenotype after
cytokine stimulation. Cells were first incubated for
30 minutes with FCS before staining to avoid non speci-
fic fixation of the antibodies.
To assess the purity of cell suspensions, cells were
stained with antibodies directed to surface molecules
not expressed by AECII: anti-human CD19-FITC (clone
4G7, mouse IgG1 kappa), CD45-PerCp (clone 2D1,
mouse IgG1 kappa), CD11b-APC (clone D12, mouse
I g G 2 ak a p p a ) ,C D 1 1 c - A P C( c l o n eS - H C L - 3 ,m o u s e
IgG2b kappa) and CD14-APC (clone MphiP9, mouse
IgG2b kappa). A goat polyclonal IgG anti-human DC-
LAMP-PE (CD208) was used to identify AECII in the
cell suspension as DC-LAMP is constitutively expressed
by AECII [29,30]. DC-LAMP staining was performed
after fixation and permeabilization of the cells (lysing
solution and permeabilization solution, BD Biosciences).
All reagents were obtained from BD Biosciences (Erem-
bodegem, Belgium), except the antibody to DC-LAMP
which was from R&D Systems Europe (Abingdon, UK).
To characterize the phenotype of the A549 cell line
and of primary AECII, the cells were stained with anti-
human antibodies to HLA-DR-PE (clone L243, mouse
IgG2a kappa), CD80-PE (clone L307.4, mouse IgG1
kappa), CD86-PE (clone FUN-1, mouse IgG1 kappa),
ICOS-L (clone 2D3/B7-H2, mouse IgG2b kappa), CD40-
FITC (clone 5C3, mouse IgG1 kappa), CD54-APC
(clone HA58, mouse IgG1 kappa), CD58-FITC (clone
1C3, mouse IgG2a kappa). All the antibodies used were
obtained from BD Biosciences.
Flow cytometric analysis was performed using a
FACSCanto II (Becton Dickinson) and the FlowJo soft-
ware (Tree Star, Ashland, OR, USA). Both the percen-
tages of positive cells and the median of fluorescence
intensity (MFI) were evaluated for each triplicate. For
the MFI analysis, specific fluorescence intensity varia-
tions observed after activation were determined by the
ratio between the MFIs of stimulated cells (MFIs) and
resting cells (MFIr). As an increase in autofluorescence
was observed during short-term cultures, the value
obtained for non-labelled cells (MFIx 0) was subtracted
from the MFI of the labelled cells (MFIx), for both rest-
ing and stimulating cells (MFIr and MFIs): (MFIs -
MFIs 0)/(MFIr - MFI r 0)
Cytokine stimulations
Cells were plated in 48 wells flat-bottomed plates (A549:
5×1 0
4 cells/well; AECII: 5 × 10
5 cells/well), and
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48 hours). In parallel to resting conditions, the cells
were in vitro stimulated with human recombinant IFN-g
(100 ng/ml), human recombinant TNF-a (50 ng/ml) or
a combination of the two cytokines (IFN-g 50 ng/ml
and TNF-a 25 ng/ml) (R&D Systems Europe) during 24
hours before analyzing their phenotype by flow cytome-
try. Seven and four independent experiments were per-
formed in triplicate for A549 cell line and AECII
respectively.
Statistics
Results are presented as mean values obtained from
triplicate and medians were used to compare groups. The
non-parametric Mann-Whitney test was applied to com-
pare phenotypic markers expression of A549 versus
AECII in resting conditions. To compare the percentages
of positive cells after cytokine stimulations versus resting
conditions, the non-parametric Kruskal-Wallis test com-
bined with the Dunn’sm u l t i p l ec o m p a r i s o nt e s tw a s
used. The non-parametric Kruskal-Wallis test associated
with the Dunn’s multiple comparison test was used to
compare MFI after stimulating conditions versus resting
condition. A value of P< 0.05 was considered to be
significant. All results were obtained with the GraphPad
Prism version 4.00 for Windows (GraphPad Software,
San Diego, CA, USA, http://www.graphpad.com).
Results
Phenotypic characterization of freshly isolated type II AEC
compared to the A549 cell line
Type II AEC isolated from human lung cultured until con-
fluence were stained with phenotypic markers and com-
pared to the A549 cell line, often used as a model of
human AECII. The cells were stained with anti-human
antibodies to HLA-DR, as it is the most strongly expressed
class II locus. Whereas a high proportion of freshly iso-
lated AECII expressed at their surface HLA-DR molecules
(median 75.44%, ranges: 68.73% - 84.68%), only a minority
of A549 cells did express this marker (11.40%, 0.03% -
16.60%), resulting in significant differences in the expres-
sion of MHC class II molecules between the two types of
cell suspensions (P < 0.01) (Figure 1).
Analysis of the expression of the co-stimulatory mole-
cules from the B7 family indicated that few cells of both
suspensions express these markers. The study of the
fresh AECII showed almost no expression of CD80
(7.22%, 4.26% - 10.14%), a low expression of CD86
Figure 1 Phenotypic characterization by flow cytometry of A549 cells compared to freshly-isolated AECII in resting conditions.A 5 4 9
cell line and fresh isolated AECII were cultured until confluence and stained with the indicated surface antibodies for phenotypic analysis by
flow cytometry. Each experimental condition (seven for A549 cell line and five for AECII) was performed in triplicate, the mean value being
represented by a dot. Medians are represented as horizontal bars. A value of P< 0.05 was considered to be significant. ** P < 0.01.
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8.32% - 16.76%). Similar results were obtained for the
c e l ll i n eA 5 4 9( F i g u r e1a n dd a t an o ts h o w nf o rI C O S -
L). The CD40 molecule was expressed only on a very
low proportion of epithelial cells, respectively on 12.54%
of the AECII (3.66% - 14.41%) and on 7.37% of the
A549 cells (2.75% - 9.43%) (Figure 1).
In contrast, two other co-stimulatory molecules were
expressed on the surface from most cells of both A549 cell
line and fresh AECII. CD54 was expressed on nearly all
the freshly isolated type II AEC (97.37%, 94.88% - 99.55%)
and on an important proportion of A549 cells (59.21%,
39.68% - 71.21%), with however significant differences in
the proportions of positive cells within the cell suspensions
(P < 0.01) (Figure 1). Conversely, CD58 was expressed on
nearly all the A549 cells (98.54%, 97.70% - 98.89%) and on
a lower percentage of freshly isolated cells (58.99%, 52.07%
-7 3 . 2 3 % )( P < 0.01 ) (Figure 1).
These results indicate the constitutive surface expres-
sion of HLA-DR on freshly isolated AECII and the low
expression of this molecule on the A549 cell line. The
presence of alternative co-stimulatory molecules was
highlighted for the two cell suspensions, as well as the
very low or even absent expression of the B7 family
molecules.
Modulation of A549 phenotypic markers expression with
inflammatory cytokines
In the course of a pulmonary infection, alveolar epithe-
lial cells will be exposed to different inflammatory cyto-
kines released by cells involved in the innate immunity
that could modulate the expression of phenotypic mar-
kers. We therefore analyzed the expression of these
markers in A549 cell line in presence of IFN-g and/or
TNF-a.
The results illustrated on Figure 2 are expressed as
percentages of positive cells and as a ratio between the
MFI obtained under stimulating conditions and those
obtained on resting cells (Figure 3). The percentages of
HLA-DR-expressing cells as well as the HLA-DR and
Figure 2 Modulation of the A549 phenotype by IFN-g and/or TNF-a (in percentage). The A549 cells were incubated during 24 hrs with
human recombinant IFN-g (100 ng/ml, I100), TNF-a (50 ng/ml, T50) or both cytokines (50 ng/ml IFN-g and 25 ng/ml TNF-a, I50/T25). The
phenotype was analyzed by flow cytometry. The horizontal bars represent the medians of the results from seven independent experiments
(each performed in triplicate). Mean values and medians are represented as dots and bars respectively. A value of P< 0.05 was considered to be
significant. * P < 0.05;** P < 0.01; *** P < 0.001.
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and/or TNF-a. In contrast, both the proportion of
CD54-positive cells and the CD54-MFI were signifi-
cantly higher in the presence of TNF-a (P < 0.01) and
when the cells were cultured with the combination of
IFN-g and TNF-a (P < 0.001). The percentage of cells
expressing CD80 was not induc e db yc y t o k i n es t i m u l a -
tions, only some increase of the CD80-MFI was noted
in the presence of the combination of IFN-g and TNF-a
(P < 0.01). Finally, the combined stimulation with IFN-g
and TNF-a increased both the proportion of CD86 and
CD40-positive cells and the MFI of these molecules (P <
0.05 for CD86 positive cells and CD86 MFI; and P <
0.01 and P < 0.05 for CD40 positive cells and CD40
MFI respectively).
Modulation of fresh human AECII phenotypic markers
expression with inflammatory cytokines
The effect of IFN-g and/or TNF-a on the expression of
phenotypic markers were also evaluated on freshly iso-
lated AECII as phenotypic differences were observed
compared to the A549 cell line.
The percentages of type II AEC expressing HLA-DR or
the different co-stimulatory molecules investigated here
were not different after incubating the cells with IFN-g and/
or TNF-a when compared to the resting cells (Figure 4). In
contrast, a slight but significant increase in the MFI of dif-
ferent phenotypic markers was observed in the presence of
the inflammatory cytokines indicating that the density of
the markers at the cell surface was higher even if the pro-
portion of positive cells did not increase (Figure 5). Higher
expression of HLA-DR was observed in the presence of
IFN-g and the combination of cytokines (P < 0.05). Simi-
larly, a significantly higher expression of CD54 was noted
after incubation of the cells especially with both IFN-g and
TNF-a (P < 0.01). The combination of the two cytokines
also induced a higher expression of CD40 (P <0 . 0 5 ) .N o
change was noted in the cell surface expression of CD80,
CD86 and CD58 molecules, the last one being expressed at
basal level by the majority of the cells.
These results on the increase in the expression of
CD54 suggest a possible major implication of this mole-
cule in the immunological synapse, without excluding a
role for CD58 in co-stimulatory signal transduction.
Figure 3 Modulation of the phenotypic markers density of A549 by inflammatory cytokines. These results were obtained from the same
samples as those presented in Figure 2 but relative medians of fluorescence intensity (MFI) were analyzed. Results are represented by the
medians and the inter-quartile ranges obtained for seven independent experiments. A value of P< 0.05 was considered to be significant. * P <
0.05;** P < 0.01; *** P < 0.001. I100: IFN-g 100 ng/ml; T50: TNF-a 50 ng/ml; I50/T25: IFN-g 100 ng/ml, TNF-a 25 ng/ml.
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If the role of AECII in the innate immune system is well
recognized, their role as accessory antigen-presenting cells
has been more recently proposed. However, until now dif-
ferent contradictory results have been published both con-
cerning the surface-expressed molecules involved in
antigen presentation and the in vitro T lymphocyte
response to AECII-presented antigens [13,15-19,31,32].
We postulated that such differences could be due to the
use of different cell types (cell line or not), and to the
absence of standardization of the techniques used to ana-
lyze these markers. The expression of co-stimulatory
molecules by AECII was first reported but recent papers
claim that some markers are absent and could contribute
to an unresponsiveness of T lymphocytes to AECII stimu-
lation. However, as interstitial lung lymphocytes comprise
as much CD8
+ and CD4
+ lymphocytes [Beukinga I, perso-
nal communication], we carefully compared here the
classically used model of type II AEC, the A549 cell line,
to freshly isolated AECII, for their surface expression of
the major markers involved in the immunological synapse.
As these surface molecules can be modulated by
inflammatory molecules released during lung infections,
we further analyzed the modulation of these markers
expression by two major inflammatory cytokines, IFN-g
and TNF-a [17,21-26]. We adapted the protocol described
by I.R. Witherden and T.D. Tetley for the isolation of
AECII as the recommended enzymatic treatment with
trypsin does not affect the expression of surface markers
on AECII [13], in contrast to dispase sometimes used to
isolate AECII and who degrades ICOS-L [18].
The expression of MHC-II molecules is mandatory for
the antigen presentation to CD4
+ T lymphocytes and we
confirmed that freshly isolated AECII have a high constitu-
tive surface expression of HLA-DR molecules as described
by Cunningham et al. [31] whereas the A549 cell line did
not expressed the MHC-II molecules. The MHC-II mole-
cules expression of the latest one was even not modulated
by IFN-g and/or TNF-a. These two last observations rein-
force the data obtained by Redondo et al. who find a very
low expression of MHC-II molecules by the A549 cell line
with no modulation by IFN-g [21]. In contrast, we reported
here that the constitutive MHC-II molecules expression by
freshly isolated cells was significantly upregulated by IFN-g
Figure 4 Modulation of fresh AECII phenotype by IFN-g and/or TNF-a (in percentage). AECII were treated as was A549 cell line in Figure 2.
Four independent experiments were performed in triplicate, each point representing the mean value. The bars represent the medians. Results
were compared to their resting conditions. I100: IFN-g 100 ng/ml; T50: TNF-a 50 ng/ml; I50/T25: IFN-g 100 ng/ml, TNF-a 25 ng/ml.
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to present antigens to CD4
+ T lymphocytes. These data
differ from those reported by Debabbi et al. [17], most
probably as a consequence of differences in the set up ana-
lysis used. Indeed, as stressed in the Material and Methods
section, we subtracted the auto-fluorescence of non-stained
cells before comparing the MFI from stimulating and rest-
ing cells to take into account the observed MFI increase of
the resting cells, probably secondary to morphological
changes.
In addition to the expression of MHC molecules, anti-
gen presentation to lymphocytes usually needs co-stimula-
tory signals. The most powerful one is given by the
B7/CD28 interaction [33]. In agreement with Cunningham
et al., we showed here a lack of expression of CD80 (B7-1)
and a low expression of CD86 (B7-2) both on the A549
cell line and on the freshly isolated AECII [31]. Only a
slight increase in the densities of CD80 and CD86 and in
the number of CD86 expressing cells on the A549 cell line
was noted in the presence of IFN-g and TNF-a.A n o t h e r
member of the B7 family, ICOS-L (B7-H2), has been
described as playing a role in the activation of memory
T lymphocytes [34], but we did not confirm its previously
reported expression on AECII [26]. Indeed, we found a
very low expression of ICOS-L with no modulation, both
on the A549 cell line and on the freshly isolated AECII
(data not shown). Globally, these results indicate that B7
family molecules are expressed only at low level by AECII
and that their surface expression is not strongly induced
upon activation, as opposed to professional APC, such as
activated dendritic cells or macrophages. Finally, the
expression of CD40 was also shown to be low at the basal
state on both cell types with however a slight but signifi-
cant increase after stimulation with the combination of
IFN-g and TNF-a. Whether the increased expression of
these molecules observed in both A549 and AECII, has an
impact on the antigenic presentation need to be proved.
All these data suggest that AECII are probably not able
to activate neither naive nor memory T lymphocytes by
the classical pathway. However, alternative co-stimulatory
signals have been reported allowing the stimulation in
recall responses of CD4
+ and CD8
+ T lymphocytes in the
absence of B7/CD28 interaction. This pathway involves the
CD54/LFA-1 and/or CD58/CD2 interactions [35-37]. Both
Figure 5 Modulation of the phenotypic markers density of fresh AECII by inflammatory cytokines. These results were obtained from the
same samples as those presented in Figure 4 but relative medians of fluorescence intensity (MFI) were analyzed. Results are represented by the
medians and the inter-quartile ranges obtained with four independent experiments. A value of P< 0.05 was considered to be significant. * P <
0.05;** P < 0.01. I100: IFN-g 100 ng/ml; T50: TNF-a 50 ng/ml; I50/T25: IFN-g 100 ng/ml, TNF-a 25 ng/ml.
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CD54 and CD58 with a higher level of expression of CD54
and a lower expression of CD58 on the AECII compared
to the A549 cell line. Even if no regulation of the expres-
sion of CD58 was observed after cytokines stimulation, its
high basal expression suggests that this molecule could
play a role in the immunological synapse and allow effi-
cient lymphocyte activation as shown for endothelial cells
[36]. In contrast, the expression of CD54 was highly upre-
gulated after cytokines stimulation on both cell types. The
role of these molecules when the B7/CD28 interaction is
lacking was previously shown in a mouse model [35].
Therefore, we suggest that both CD58 and CD54 could
play a major role in the antigenic presentation by AECII
and that these cells could be able to present antigens to
both CD4
+ and CD8
+ T lymphocytes.
Conclusions
A549 cell line is not suitable to analyze the antigen pre-
sentation to CD4
+ T lymphocytes as it lacks the MHC-
II surface expression. However, as it kept the expression
of MHC-I molecules, as well as the expression of CD54
and CD58, this cell line could be appropriate to study
the interactions with CD8
+ T lymphocytes. In contrast,
freshly isolated AECII could play a role in the activation
of both CD4
+ and CD8
+ T lymphocytes as they
expresses MHC-II and MHC-I molecules as well as
alternative co-stimulatory CD54 and CD58.
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